@EdinMifsud et al. studied how different #influenza subtypes affect the duration of susceptibility to secondary #bacterial#infections. Understanding the susceptibility window could improve diagnosis, leading to better clinical outcomes. #FEMSMicrobes
https://t.co/Y3RQ1RLncn
Leaving academia is not leaving research.
Leaving academia is not leaving science.
Leaving academia is not failing.
Not sure who needs to hear this today, but please believe it.
This is how much Australia spent on medical research in 2015 compared to other countries. We’re down near the bottom. I’m confused. Why are we spending billions on submarines?
#JVirology SPOTLIGHT from Schultz-Cherry @SSCLabQuips lab! Immortalized nasal and tracheal swine respiratory epithelial cell lines that maintain features of respiratory tract provide new tools for Influenza virus research.
https://t.co/BjvC93UJsy
Australia has hundreds of outstanding research projects that are "shovel ready". If funded these would drive innovation & excellence for years to come, and protect jobs right now @GregHuntMP
Visited @TheDohertyInst today with @DanielAndrewsMP to announce $155m for a new Australian Institute for Infectious Disease. A visionary project that will confirm and enhance our place as a world leader in #medicalresearch; create thousands of jobs; and improve and save lives 🦠
Please retweet - we are recruiting patients to understand the role of diabetes in long-term immunity to COVID19 - If you have recovered from COVID19 in Queensland please consider joining our study so we can help make a difference during this pandemic!
CSL, @CEPIvaccines and #UQ today announced a partnering agreement to accelerate the development, manufacture and distribution of a #COVID19 vaccine candidate, utilising #UQ’s “molecular clamp” enabled vaccine. #UQ aim to commence phase 1 clinical trials in July.
Shutdown puts other medical research on hold. This is a really serious issue for all our health. Very much hoping all medical research in Australia can return to work ASAP @TheDohertyInst @unimelb https://t.co/1WEcPJvfND
Researchers from @TheDohertyInst and @imperialcollege have shown that a new antiviral drug for influenza, baloxavir, can treat the infection at the same time as reducing the risk of transmission to others https://t.co/Jk8IOXqbEn @unimelb @UniMelbMDHS @TheRMH